AKT1 and colorectal carcinoma: EGFR was enriched in CRC, EGFR tyrosine kinase inhibitor resistance, the FoxO signaling pathway, the Oxytocin signaling pathway, the JAK-STAT signaling pathway, the Pl3K-Akt signaling pathway, and hedgehog signaling pathway.